USANA Health Sciences, Inc.
USANA Health Sciences, Inc. (NYSE: USNA) develops and manufactures nutritional supplements, functional foods, and personal care and skincare products for consumers worldwide. Its core nutritional business sells mainly through independent Brand Partners, Preferred Customers, and retail customers, while its Hiya… From the company’s description.
Over the twelve months to Jul 4, 2026, USANA Health Sciences, Inc. reported revenue of $913.36M, up 1.6% from a year earlier, and a net loss of $29.25M. Its operating margin was −0.1%, and operations generated $27.73M in cash. In fiscal 2025, it reported revenue of $925.26M, up 8.3% from fiscal 2024, and net income of $11.48M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What USANA Health Sciences, Inc. does
In the company’s own words
USANA Health Sciences, Inc. (NYSE: USNA) develops and manufactures nutritional supplements, functional foods, and personal care and skincare products for consumers worldwide. Its core nutritional business sells mainly through independent Brand Partners, Preferred Customers, and retail customers, while its Hiya business reaches consumers primarily through direct-to-consumer subscriptions; the company also sells through online marketplaces and retail channels. USANA reports two segments: Core nutritional and Hiya direct-to-consumer, with Rise and Oola included in an “other” category. Core products include supplements, meal replacements, snack bars, and Celavive skincare; Hiya focuses on children’s health products, and Rise sells protein bars and drinks. In 2025, USANA generated $925 million in net sales, served approximately 387,000 active Customers in its core nutritional business, and operated in 25 geographic markets. The company acquired Rise and Oola in 2022 and a 78.85% interest in Hiya in 2024, expanding beyond its traditional direct-selling model. Its website is www.usana.com.
Company details
- Sector
- Consumer Staples
- Industry (SIC)
- Chemicals
- Headquarters
- SALT LAKE CITY, UT
- Fiscal year end
- January
- CIK
- 896264
- SIC
- 2833
Financial performance, year by year
Fiscal 2011–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns USANA Health Sciences, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · USANA Health Sciences, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do USANA Health Sciences, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of USANA Health Sciences, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in USANA Health Sciences, Inc.'s last four quarterly filings that the numbers alone won't show?”